Alexza Pharmaceuticals News

News on Alexza Pharmaceuticals (Ticker: ALXA) continually updated from thousands of sources around the net.

Saturday Jun 15 | PR-inside.com

New Market Research Report: Alexza Pharmaceuticals, Inc. - Product Pipeline Review - 2013

The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Comment?

Related Topix: Startups

Thu Jun 13, 2013

Seeking Alpha

Valuing Alexza After The Teva Adasuve Deal

On May 8, 2013, Alexza Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc. announced that the two companies have entered into an exclusive U.S. license and supply agreement for ADASUVE inhalation powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

Comment?

Related Topix: Startups

Mon Jun 10, 2013

Freshnews

SteadyMed Therapeutics, Inc. Further Strengthens Management Team With ...

SteadyMed Therapeutics, Inc. , a private drug delivery therapeutics company, today announced that Peter Noymer, Ph.D. has joined the company as EVP of R&D and CTO, and Rick White has joined as VP BD and Commercial Operations.

Comment?

Related Topix: Startups, Marketing

Mon Jun 03, 2013

Freshnews

Agendia Appoints Peter W. Schineller as Chief Commercial Officer

Agendia, a leader in molecular cancer diagnostics, today announced the addition of Peter W. Schineller as its Chief Commercial Officer.

Comment?

Related Topix: Startups, Marketing, Public Relations